Voyager Therapeutics (VYGR) Misses Q1 EPS by 8c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of ($0.53), $0.08 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $6.47 million versus the consensus estimate of $12.95 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Axis Capital Limited Upgrades Coforge Ltd (COFORGE:IN) to Buy (1)
• Axis Capital Limited Upgrades LTM Ltd (LTM:IN) to Buy (1)